Role of type 3 innate lymphoid cell in airway immunity in children

HUANG Yongxia; XIONG Yi

doi:10.7619/jcmp.20214631

Journal of Clinical Medicine in Practice > 2022 > 26(5): 144-148. > DOI: 10.7619/jcmp.20214631

HUANG Yongxia, XIONG Yi. Role of type 3 innate lymphoid cell in airway immunity in children[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 144-148. DOI: 10.7619/jcmp.20214631

Citation:

HUANG Yongxia, XIONG Yi. Role of type 3 innate lymphoid cell in airway immunity in children[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 144-148. DOI: 10.7619/jcmp.20214631

Citation:

HUANG Yongxia, XIONG Yi. Role of type 3 innate lymphoid cell in airway immunity in children[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 144-148. DOI: 10.7619/jcmp.20214631

PDF (629 KB)

Role of type 3 innate lymphoid cell in airway immunity in children

HUANG Yongxia,
XIONG Yi^,

Department of Pediatrics, Maternal and Child Health Hospital Affiliated to Zunyi Medical University, Zunyi, Guizhou, 563000

More Information

Received Date: November 23, 2021
Available Online: March 28, 2022
Published Date: March 14, 2022

Graphical Abstract

Abstract

Abstract

Epithelial cells of the lungs secrete inflammatory mediators to activate resident immune cells in the airway for immune protection after stimulation, including innate lymphoid cells. Although the number of innate lymphoid cells is less, they can secrete numerous cytokines involving in immune response. Type 3 innate lymphoid cells (ILC3) are important subtype of innate lymphoid cells. ILC3 and its secreted cytokines interleukin (IL)-17 and IL-22 play immune defense roles in clearing pathogens, promoting mucosal repair and maintaining mucosal barrier homeostasis in respiratory infections. In this review, the development and activation mechanisms of ILC3 and its roles in pediatric airway inflammatory diseases, and latest research progress were summarized.
- type 3 innate lymphoid cells,
- activation,
- airway immunity,
- respiratory tract infection

FullText(HTML)

References (40)

References

[1]	DIEFENBACH A, COLONNA M, KOYASU S. Development, differentiation, and diversity of innate lymphoid cells[J]. Immunity, 2014, 41: 354-365. doi: 10.1016/j.immuni.2014.09.005
[2]	ARTIS D, SPITS H. The biology of innate lymphoid cells[J]. Nature, 2015, 517(7534): 293-301. doi: 10.1038/nature14189
[3]	HARLY C, KENNEY D, REN G, et al. The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage[J]. Nature Immunology, 2019, 20(9): 1150-1160. doi: 10.1038/s41590-019-0445-7
[4]	CONSTANTINIDES M G, MCDONALD B D, VERHOEF P A, et al. A committed precursor to innate lymphoid cells[J]. Nature, 2014, 508(7496): 397-401. doi: 10.1038/nature13047
[5]	HARLY C, CAM M, KAYE J, et al. Development and differentiation of early innate lymphoid progenitors[J]. Journal of Experimental Medicine, 2018, 215(1): 249-262. doi: 10.1084/jem.20170832
[6]	VIVIER E, ARTIS D, COLONNA M, et al. Innate lymphoid cells: 10 years on[J]. Cell, 2018, 174(5): 1054-1066. doi: 10.1016/j.cell.2018.07.017
[7]	WANG Q L, COLONNA M. Keeping time in group 3 innate lymphoid cells[J]. Nat Rev Immunol, 2020, 20(12): 720-726. doi: 10.1038/s41577-020-0397-z
[8]	MONTALDO E, TEIXEIRA-ALVES L G, GLATZER T, et al. Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells[J]. Immunity, 2014, 41(6): 988-1000. doi: 10.1016/j.immuni.2014.11.010
[9]	HE L, ZHOU M, LI Y C. Vitamin D/vitamin D receptor signaling is required for normal development and function of group 3 innate lymphoid cells in the gut[J]. iScience, 2019, 17: 119-131. doi: 10.1016/j.isci.2019.06.026
[10]	GRAY J, OEHRLE K, WORTHEN G, et al. Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection[J]. Science Translational Medicine, 2017, 9(376): eaaf 9412. doi: 10.1126/scitranslmed.aaf9412
[11]	CRELLIN N K, TRIFARI S, KAPLAN C D, et al. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2[J]. Immunity, 2010, 33(5): 752-764. doi: 10.1016/j.immuni.2010.10.012
[12]	GURCZYNSKI S J, MOORE B B. IL-17 in the lung: the good, the bad, and the ugly[J]. AJP Lung Cellular and Molecular Physiology, 2018, 314(1): L6-L16. doi: 10.1152/ajplung.00344.2017
[13]	APARICIO-DOMINGO P, ROMERA-HERNANDEZ M, KARRICH J J, et al. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage[J]. Journal of Experimental Medicine, 2015, 212(11): 1783-1791. doi: 10.1084/jem.20150318
[14]	GUO X H, QIU J, TU T, et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection[J]. Immunity, 2014, 40(1): 25-39. doi: 10.1016/j.immuni.2013.10.021
[15]	RÖSLER BARBARA, HEROLD SUSANNE. Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy?[J]. Molecular and Cellular Pediatrics, 2016, 3(1): 29. doi: 10.1186/s40348-016-0055-5
[16]	VAN MAELE L, CARNOY C, CAYET D, et al. Activation of type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection[J]. Journal of Infectious Diseases, 2014, 210(3): 493-503. doi: 10.1093/infdis/jiu106
[17]	MORTHA A, CHUDNOVSKIY A, HASHIMOTO D, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis[J]. Science, 2014, 343(6178): 1249288. doi: 10.1126/science.1249288
[18]	KIM H Y, LEE H J, CHANG Y J, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity[J]. Nat Med, 2014, 20(1): 54-61. doi: 10.1038/nm.3423
[19]	GOLEBSKI K, ROS X R, NAGASAWA M, et al. IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation[J]. Nat Commun, 2019, 10(1): 2162. doi: 10.1038/s41467-019-09883-7
[20]	BERNINK J H, OHNE Y, TEUNISSEN M B M, et al. C-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies[J]. Nat Immunol, 2019, 20(8): 992-1003. doi: 10.1038/s41590-019-0423-0
[21]	SCHIERING C, WINCENT E, METIDJI A, et al. Feedback control of AHR signalling regulates intestinal immunity[J]. Nature, 2017, 542(7640): 242-245. doi: 10.1038/nature21080
[22]	MICHAUDEL C, BATAILLE F, MAILLET I, et al. Ozone-induced aryl hydrocarbon receptor activation controls lung inflammation via interleukin-22 modulation[J]. Front Immunol, 2020, 11: 144. doi: 10.3389/fimmu.2020.00144
[23]	QI H B, LI Y Y, YUN H, et al. Lactobacillus maintains healthy gut mucosa by producing L-Ornithine[J]. Commun Biol, 2019, 2: 171. doi: 10.1038/s42003-019-0424-4
[24]	QIU J, HELLER J J, GUO X H, et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells[J]. Immunity, 2012, 36(1): 92-104. doi: 10.1016/j.immuni.2011.11.011
[25]	HUGHES T, BRIERCHECK E L, FREUD A G, et al. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells[J]. Cell Rep, 2014, 8(1): 150-162. doi: 10.1016/j.celrep.2014.05.042
[26]	KISS E A, VONARBOURG C, KOPFMANN S, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles[J]. Science, 2011, 334(6062): 1561-1565. doi: 10.1126/science.1214914
[27]	GRONKE K, HERNÅNDEZ P P, ZIMMERMANN J, et al. Interleukin-22 protects intestinal stem cells against genotoxic stress[J]. Nature, 2019, 566(7743): 249-253. doi: 10.1038/s41586-019-0899-7
[28]	TEUFEL C, HORVATH E, PETER A, et al. mTOR signaling mediates ILC3-driven immunopathology[J]. Mucosal Immunol, 2021, 14(6): 1323-1334. doi: 10.1038/s41385-021-00432-4
[29]	FEI T, ROSER T P, BIIN S, et al. ILC3s control airway inflammation by limiting T cell responses to allergens and microbes[J]. Cell Rep, 2021, 37(8): 110051. doi: 10.1016/j.celrep.2021.110051
[30]	NAOKI I, IVY S, ALANNA W, et al. Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection[J]. JCI Insight, 2020, 5(8): e135591. doi: 10.1172/jci.insight.135591
[31]	GIACOMIN P R, MOY R H, NOTI M, et al. Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity[J]. Journal of Experimental Medicine, 2015, 212(10): 1513-1528. doi: 10.1084/jem.20141831
[32]	AZAD M B, KONYA T, PERSAUD R R, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study[J]. BJOG, 2016, 123(6): 983-993. doi: 10.1111/1471-0528.13601
[33]	RUSSELL S L, GOLD M J, HARTMANN M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma[J]. EMBO Rep, 2012, 13(5): 440-447. doi: 10.1038/embor.2012.32
[34]	XIONG H Z, KEITH J W, SAMILO D W, et al. Innate lymphocyte/Ly6C(hi) monocyte crosstalk promotes Klebsiella pneumoniae clearance[J]. Cell, 2016, 165(3): 679-689. doi: 10.1016/j.cell.2016.03.017
[35]	OHERLE K, ACKER E, BONFIELD M, et al. Insulin-like growth factor 1 supports a pulmonary niche that promotes type 3 innate lymphoid cell development in newborn lungs[J]. Immunity, 2020, 52(2): 275-294. e9. doi: 10.1016/j.immuni.2020.01.005
[36]	蔡佳玉, 卢红艳, 苏兆亮, 等. 支气管肺发育不良小鼠肺组织3型固有淋巴细胞(ILC3)数量及相关细胞因子IL-17和IL-22分泌增加[J]. 细胞与分子免疫学杂志, 2020, 36(10): 865-870. https://www.cnki.com.cn/Article/CJFDTOTAL-XBFM202010001.htm
[37]	ARDAIN A, DOMINGO-GONZALEZ R, DAS S, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis[J]. Nature, 2019, 570(7762): 528-532. doi: 10.1038/s41586-019-1276-2
[38]	WARREN K J, POOLE J A, SWEETER J M, et al. Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation[J]. Respir Res, 2021, 22(1): 206. doi: 10.1186/s12931-021-01799-5
[39]	KIM J, CHANG Y N, BAE B, et al. Innate immune crosstalk in asthmatic airways: innate lymphoid cells coordinate polarization of lung macrophages[J]. J Allergy Clin Immunol, 2019, 143(5): 1769-1782. e11. doi: 10.1016/j.jaci.2018.10.040
[40]	HAM J, KIM J, CHOI S, et al. Interactions between NCR+ILC3s and the microbiome in the airways shape asthma severity[J]. Immune Netw, 2021, 21(4): e25. doi: 10.4110/in.2021.21.e25

[1]	LI Panying, ZHANG Xiaofeng, YIN Jianyun, REN Xiaowei, YANG Jing, NI Qian. Research progress on genetic factors related to lung function[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 133-137, 143. DOI: 10.7619/jcmp.20244444
[2]	GUO Lingjuan. Evidence-based nursing intervention in improving the level of inhalation and lung function in patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2017, (20): 18-20,24. DOI: 10.7619/jcmp.201720006
[3]	ZHANG Li, CHEN Jianguo. Influence of health belief nursing intervention on cognitive impairment and quality of life of patients with Alzheimer's disease[J]. Journal of Clinical Medicine in Practice, 2017, (14): 27-30. DOI: 10.7619/jcmp.201714008
[4]	XIAO Jian, ZHANG Hao, PAN Chunhong. Effect of quality nursing intervention on compliance and pulmonary function in children with asthma[J]. Journal of Clinical Medicine in Practice, 2017, (12): 119-121,125. DOI: 10.7619/jcmp.201712035
[5]	ZHANG Minghua, SHUI Mingming, YAO Jun, FAN Wanli. Effect of bronchoalveolar lavage combined with mechanical ventilation on clinical symptoms and lung function of elderly patients with severe asthma[J]. Journal of Clinical Medicine in Practice, 2017, (11): 45-47. DOI: 10.7619/jcmp.201711014
[6]	ZHANG Li, DU Xingzhen. Effect of continuity nursing on lung function and quality of life in patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2017, (4): 40-43. DOI: 10.7619/jcmp.201704013
[7]	YANG Xurong, AO Dongmei, QIN Qin. Influence of comprehensive rehabilitation nursing on lung function in elderly patients with COPD[J]. Journal of Clinical Medicine in Practice, 2015, (4): 23-25. DOI: 10.7619/jcmp.201504008
[8]	YUE Juxia, FAN Xiaokang. Clinical application of inhaled glucocorticosteroid in children with bronchiolitis and its influence for lung function[J]. Journal of Clinical Medicine in Practice, 2013, (16): 117-119. DOI: 10.7619/jcmp.201316046
[9]	ZHANG Xueman, PAN Hongchi, WANG Hongjun. Efficacy of montelukast in the treatment of bronchial asthma and its effect on pulmonary function[J]. Journal of Clinical Medicine in Practice, 2013, (15): 62-63. DOI: 10.7619/jcmp.201315022
[10]	ZHAO Lining. Effects of Xin Qin alevaire on lung function,EOS and IgE in patients with bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2013, (11): 25-27,37. DOI: 10.7619/jcmp.201311008

Cited By

Get Citation

PDF

XML

Article views (253) PDF downloads (18)

Turn off MathJax

Article Contents

Abstract

References

Role of type 3 innate lymphoid cell in airway immunity in children

Abstract

References

Related Articles

Catalog

Role of type 3 innate lymphoid cell in airway immunity in children

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content